Myths vs facts: TCF7L2 and fatigue

TCF7L2 is a transcription factor strongly associated with type 2 diabetes risk. Evidence for a direct link to fatigue is weak. Fatigue can be a symptom of undiagnosed diabetes or insulin resistance, but the gene itself does not cause exhaustion. Consumer tests linking TCF7L2 variants to fatigue rely on indirect associations and marketing. Effect sizes are small, and clinical relevance for individual fatigue perception is unclear. A common myth is that the TCF7L2 variant directly causes chronic fatigue. Fact: The variant increases diabetes risk, and diabetes can cause fatigue – but this is an indirect pathway. Moreover, many other factors (sleep, stress, diet, exercise) play a much larger role. Anyone experiencing fatigue should seek medical evaluation rather than rely on DNA tests. The evidence level is best rated as 'marketing/unclear' because no robust studies demonstrate a direct causal link.